Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection (Q41347626)

29 September 2017

Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection (English)

1 reference

29 September 2017

1 reference

1

Arnold S Monto

1 reference

29 September 2017

8

Jacqueline M Katz

1 reference

29 September 2017

9

Suzanne E Ohmit

1 reference

29 September 2017

Joshua G Petrie

2

1 reference

29 September 2017

Rachel T Cross

3

1 reference

29 September 2017

Emileigh Johnson

4

1 reference

29 September 2017

Merry Liu

5

1 reference

29 September 2017

Weimin Zhong

6

1 reference

29 September 2017

Min Levine

7

1 reference

29 September 2017

language of work or name

English

0 references

publication date

8 April 2015

1 reference

Journal of Infectious Diseases

29 September 2017

1 reference

29 September 2017

212

1 reference

29 September 2017

8

1 reference

29 September 2017

1191-1199

1 reference

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

29 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Reproducibility of serologic assays for influenza virus A (H5N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Immunological assessment of influenza vaccines and immune correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Comparative efficacy of inactivated and live attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

The influenza vaccine licensing process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

Stability of neuraminidase in inactivated influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV195

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIV195

1 reference

29 September 2017

1 reference